Zucapsaicin for the treatment of neuropathic pain

Bibliography

• Szallasi A, Sheta M. Targeting TRPV1 for pain relief: limits, losers and laurels. Expert Opin Investig Drugs 2012;21(9):1351-69
   PubMed Web of Science ®Google Scholar
• Jensen TS, Baron R, Haanpää M, et al. A new definition of neuropathic pain. Pain 2011;152:2204-5
   PubMed Web of Science ®Google Scholar
• Haanpää M, Attal N, Backonja M, et al. NeuPSIG guidelines on neuropathic pain assessment. Pain 2011;152:14-27
   PubMed Web of Science ®Google Scholar
• Brederson JD, Kym PR, Szallasi A. Targeting TRP channels for pain relief. Eur J Pharmacol 2013;716:61-76
   PubMed Web of Science ®Google Scholar
• Trevisani M, Szallasi A. Targeting TRPV1. challenges and issues in pain management. Open Drug Discov J 2010;2:37-49
   Google Scholar
• Fallon MT. Neuropathic pain in cancer. Br J Anaesth 2013;111(1):105-11
   PubMed Web of Science ®Google Scholar
• Finnerup NB, Otto M, McQuay HJ, et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 2005;118(3):289-305
   PubMed Web of Science ®Google Scholar
• Gagnon B, Almahrezi A, Schreier G. Methadone in the treatment of neuropathic pain. Pain Res Manag 2003;8(3):149-54
   PubMedGoogle Scholar
• Baron R, Binder A, Wasner G. Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment. Lancet Neurol 2010;9(8):807-19
   PubMed Web of Science ®Google Scholar
• Burgess G, Williams D. The discovery and development of analgesics: new mechanisms, new modalities. J Clin Invest 2010;120:3753-9
   PubMed Web of Science ®Google Scholar
• Sałat K, Moniczewski A, Librowski T. Transient receptor potential channels - emerging novel drug targets for the treatment of pain. Curr Med Chem 2013;20(11):1409-36
   PubMed Web of Science ®Google Scholar
• Sałat K, Kowalczyk P, Gryzło B, et al. New investigational drugs for the treatment of neuropathic pain. Expert Opin Investig Drugs 2014;4:1-12
   Google Scholar
• Sałat K, Kulig K. GABA transporters as targets for new drugs. Future Med Chem 2011;3(2):211-22
   PubMed Web of Science ®Google Scholar
• Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001;24:487-517
   PubMed Web of Science ®Google Scholar
• Papoiu AD, Yosipovitch G. Topical capsaicin. The fire of a ’hot’ medicine is reignited. Expert Opin Pharmacother 2010;11(8):1359-71
   PubMed Web of Science ®Google Scholar
• O’Neill J, Brock C, Olesen AE, et al. Unravelling the mystery of capsaicin: a tool to understand and treat pain. Pharmacol Rev 2012;64(4):939-71
   PubMed Web of Science ®Google Scholar
• Jhaveri MD, Elmes SJR, Kendall DA, Chapman V. Inhibition of peripherial vanilloid TRPV1 receptors reduces noxius heat-evoked responses of dorsal horn neurons in naïve, carrageen-inflamed and neuropathic rats. Eur J Neuroscience 2005;22:361-70
   PubMed Web of Science ®Google Scholar
• Palazzo E, Luongo L, de Novellis V, et al. Moving towards supraspinal TRPV1. receptors for chronic pain relief. Mol Pain 2010;11:6-66
   Google Scholar
• Khairatkar-Joshi N, Szallasi A. TRPV1 antagonists: the challenges for therapeutic targeting. Trends Mol Med 2009;15(1):14-22
   PubMed Web of Science ®Google Scholar
• Chen Y, Yang C, Wang J. Proteinase-activated receptor 2 sensitizers transient receptor potential vanilloid 1, transient receptor potential vanilloid 4, and transient receptor potential ankyrin 1 in paclitaxel-induced neuropathic pain. Neuroscience 2011;193:440-51
   PubMed Web of Science ®Google Scholar
• Facer P, Casula MA, Smith GD, et al. Differential expression of the capsaicin receptor TRPV1 and related novel receptors TRPV3, TRPV4 and TRPM8 in normal human tissues and changes in traumatic and diabetic neuropathy. BMC Neurol 2007;7(11):1-12
   PubMedGoogle Scholar
• Hudson LJ, Bevan S, Wotherspoon G, et al. VR1 protein expression increases in undamaged DGR neurons after partial nerve injury. Eur J Neurosci 2001;13(11):2105-14
   PubMed Web of Science ®Google Scholar
• Rashid MH, Inoue M, Kondo S, et al. Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain. J Pharmacol Exp Ther 2003;304(3):940-8
   PubMed Web of Science ®Google Scholar
• Rashid MH, Inoue M, Bakoshi S, Ueda H. Increased expression of vanilloid receptor 1 on myelinated primary afferent neurons contributes to the antihyperalgesic effect of capsaicin cream in diabetic neuropatic pain in mice. J Pharmacol Exp Ther 2003;306(2):709-17
   PubMed Web of Science ®Google Scholar
• Hara T, Chiba T, Abe K, et al. Effect of paclitaxel on transient receptor potential vanilloid 1 in rat dorsal root ganglion. Pain 2013;154:822-9
   Google Scholar
• Ta LE, Bieber AJ, Carlton SM, et al. Transient receptor potential vanilloid 1 is essential for cisplatin-indused heat hyperalgesia in mice. Mol Pain 2010;6:15
   PubMed Web of Science ®Google Scholar
• Walker KM, Urban L, Medhurst SJ, et al. The VR1 antagonist capsazepine reverses mechanical hyperalgesia in models of inflammatory and neuropathic pain. J Pharmacol Exp Ther 2003;304:56-62
   PubMed Web of Science ®Google Scholar
• Wong GY, Gavva NR. Therapeutic potential of vanilloid receptor TRPV1 agonists and antagonists as analgesics: recent advances and setbacks. Brain Res Rev 2009;60:267-77
   PubMed Web of Science ®Google Scholar
• Levine JD, Alessandri-Haber N. TRP channels: targets for the relief of pain. Biochim Biophys Acta 2007;1772(8):989-1003
   PubMed Web of Science ®Google Scholar
• Sałat K, Cios A, Wyska E, et al. Antiallodynic and antihyperalgesic activity of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one compared to pregabalin in chemotherapy-induced neuropathic pain in mice. Pharmacol Biochem Behav 2014;122:173-81
   PubMed Web of Science ®Google Scholar
• Eid SR, Cortright DN. Transient receptor potential channels on sensory nerves. Handb Exp Pharmacol 2009;194:261-81
   PubMedGoogle Scholar
• Backonja M, Wallace MS, Blonsky ER, et al. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study. Lancet Neurol 2008;7(12):1106-12
   PubMed Web of Science ®Google Scholar
• Sinning C, Watzer B, De Petrocellis L, et al. Dopamides, vanillylamides, ethanolamides, and arachidonic acid amides of anti-inflammatory and analgesic drug substances as TRPV1 ligands. ChemMedChem 2008;3(12):1956-64
   PubMed Web of Science ®Google Scholar
• Gannett PM, Nagel DL, Reilly PJ, et al. Capsaicinoids: their separation, synthesis, and mutagenicity. J Org Chem 1988;53(5):1064-71
   Web of Science ®Google Scholar
• Kaga H, Miura M, Orito K. A facile procedure for synthesis of capsaicin. J Org Chem 1989;54(14):3477-8
   Web of Science ®Google Scholar
• Bevan SJ, Docherty RJ. Cellular mechanisms of the action of capsaicin. In: Wood J, editor. Capsaicin in the study of pain. Academic Press, London, England; 1993. p. 27-44
   Google Scholar
• St Pierre M, Reeh PW, Zimmermann K. Differential effects of TRPV channel block on polymodal activation of rat cutaneous nociceptors in vitro. Exp Brain Res 2009;196(1):31-44
   PubMed Web of Science ®Google Scholar
• Stucky CL, Dubin AE, Jeske NA, et al. Roles of transient receptor potential channels in pain. Brain Res Rev 2009;60(1):2-23
   PubMed Web of Science ®Google Scholar
• Lambert DG. Capsaicin receptor antagonists: a promising new addition to the pain clinic. Br J Anaesth 2009;102(2):153-5
   PubMed Web of Science ®Google Scholar
• Lambert GA, Davis JB, Appleby JM, et al. The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission. Naunyn Schmiedebergs Arch Pharmacol 2009;380(4):311-25
   PubMed Web of Science ®Google Scholar
• Holzer P. Local effector function of capsaicin-sensitive sensory nerve endings, involvement of tachykinins, calcitonin gene related peptide and other neuropeptides. Neuroscience 1988;24:739-68
   PubMed Web of Science ®Google Scholar
• Hua XY, Chen P, Hwang J, Yaksh TL. Antinociception induced by civamide, an orally active capsaicin analogue. Pain 1997;71(3):313-22
   PubMed Web of Science ®Google Scholar
• Bourne N, Bernstein DI, Stanberry LR. Civamide (cis-capsaicin) for treatment of primary or recurrent experimental genital herpes. Antimicrob Agents Chemother 1999;43(11):2685-8
   PubMed Web of Science ®Google Scholar
• Arnar DO, Cai JJ, Lee HC, Martins JB. Electrophysiologic effects of civamide (zucapsaicin) on canine cardiac tissue in vivo and in vitro. J Cardiovasc Pharmacol 1998;32(6):875-83
   PubMed Web of Science ®Google Scholar
• Bernstein JE. Method and compositions of civamide to treat disease of the intestines. WO2011100668 A4; 2011
   Google Scholar
• Clinical trials found for civamide. Available from: https://clinicaltrials.gov/ct2/results?term=civamide&Search=Search [Last accessed 10 August 2014]
   Google Scholar
• Clinical trial: Civamide in OA of the Knee(s). Available from: https://clinicaltrials.gov/ct2/show/NCT00077935?term=nct00077935&rank=1 [Last accessed 10 August 2014]
   Google Scholar
• Clinical trial: Intranasal Civamide for Episodic Cluster Headache. Available from: https://clinicaltrials.gov/ct2/show/NCT00069082?term=nct00069082&rank=1 [Last accessed 10 August 2014]
   Google Scholar
• Bernstein JE. Method for providing long-lasting pain diminishment through topical or intranasal administration of civamide. WO2005037158 A1; 2004
   Google Scholar
• Schnitzer TJ, Pelletier JP, Haselwood DM. Civamide cream 0.075% in patients with osteoarthritis of the knee: a 12-week randomized controlled clinical trial with a longterm extension. J Rheumatol 2012;39(3):610-20
   PubMed Web of Science ®Google Scholar
• Clinical trial: Evaluation of Civamide Patch in Treatment of Postherpetic Neuralgia and Post-Incisional Neuralgia. Available from: https://clinicaltrials.gov/ct2/show/NCT00845923?term=nct00845923&rank=1 [Last accessed 10 August 2014]
   Google Scholar
• Clinical trial: Civamide Nasal Solution for Postherpetic Neuralgia of the Trigeminal Nerve. Available from: https://clinicaltrials.gov/ct2/show/NCT01886313?term=nct01886313&rank=1 [Last accessed 10 August 2014]
   Google Scholar
• Saper JR, Klapper J, Mathew NT, et al. Intranasal civamide for the treatment of episodic cluster headaches. Arch Neurol 2002;59(6):990-4
   PubMed Web of Science ®Google Scholar
• National Institute for Health Research (NIHR). (Civamide) for episodic cluster headache. NIHR HSC ID: 7234
   Google Scholar